Loading...
XSWX
GALE
Market cap4.96bUSD
Sep 17, Last price  
82.90CHF
1D
0.73%
1Q
-1.54%
IPO
92.79%
Name

Galenica AG

Chart & performance

D1W1MN
XSWX:GALE chart
P/E
22.81
P/S
1.00
EPS
3.63
Div yield, %
2.79%
Shrs. gr., 5y
0.16%
Rev. gr., 5y
3.51%
Revenues
4.14b
+5.47%
2,826,272,0002,914,917,0003,008,851,0003,145,400,0003,171,342,0003,306,237,0003,479,753,0003,834,679,0004,014,348,0003,746,011,0003,921,081,0004,135,621,000
Net income
181m
-1.01%
81,824,00081,122,00083,393,000118,804,000147,546,000124,992,000172,245,000167,680,000165,132,000173,598,000182,951,000181,099,000
CFO
300m
+13.25%
84,118,000132,435,000156,818,000144,399,000173,550,000250,438,000224,360,000333,095,000236,873,000225,710,000264,703,000299,765,000
Dividend
Apr 23, 20262.5 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Galenica AG, a Bern, Switzerland-based company founded in 1927, functions as a prominent healthcare service provider, operating across Switzerland and on an international scale. Its comprehensive operations are strategically divided into two primary segments: Products & Care, and Logistics & IT. Within the Products & Care division, Galenica manages an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner locations. These operate under established brand names such as Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy management, this segment is also responsible for delivering medication for at-home patient treatment, launching and distributing a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, and providing dedicated marketing and sales assistance to its healthcare industry collaborators. The Logistics & IT segment delivers a suite of specialized pre-wholesale services to pharmaceutical and other healthcare enterprises. These offerings encompass storage, efficient distribution, and debt collection. Furthermore, this division provides broader logistics and IT infrastructure, including a master data system specifically designed for the healthcare sector. It also focuses on developing sophisticated management solutions for the healthcare market and is responsible for publishing both digital and print technical information about pharmaceutical products, in addition to offering comprehensive management platforms for pharmacies.

Key people

Daniela Bosshardt-Hengartner
Independent Chairwoman of the Board of Directors · since 2019
Felix Burkhard
Chief Financial Officer, Member of the Corporate Executive Committee, Head Investor Relations · since 2017
Daniele Madonna
Member of the Corporate Executive Committee, Head of Retail Business Sector · since 2017
Independent Member of the Board of Directors� · since 2017
Independent Member of the Board of Directors� · since 2019
Andreas Walde
Independent Member of the Board of Directors� · since 2017
IPO date
Apr 07, 2017
Employees
7,673
Domiciled in
CH
Incorporated in
CH
Headquarters & legal address
Untermattweg 8
Bern, BE 3027
CH
Other language
Galenica Ltd.
Other language
Galenica SA

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT